Trending Now
Exelixis Inc. (NASDAQ:EXEL) Reports Revenue Of $231.1 Million In Q3 2020...
Exelixis Inc. (NASDAQ:EXEL) has announced its Q3 2020 results in which revenue was $231.1 million and also offered an update about the progress of...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Progenity Inc. (NASDAQ: PROG) Receives Four Patents Covering Gastrointestinal Technologies ...
Progenity Inc. (NASDAQ: PROG) has received four patents from the US Patent and trademark Officer associated with its ingestible technologies for therapeutics delivery through...
MAKE IT MODERN
LATEST REVIEWS
Novavax Inc. (NASDAQ:NVAX) Shares Jump Following CEPI’s $384 Million Cash Infusion...
Novavax Inc. (NASDAQ:NVAX) has been performing poorly in recent times, but its stock received a boost recently following a $384 million from the Coalition...
MAKE IT MODERN
PERFORMANCE TRAINING
Obseva SA (NASDAQ: OBSV) Receives Another Positive Review From the CHMP
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has repeated its positive review of Obseva SA's (NASDAQ: OBSV) Linzagolix....
Coherus BioSciences Inc. (NASDAQ:CHRS) Reports Product Revenue Of $113.6 Million In Q3 2020 Attributable...
Coherus BioSciences Inc. (NASDAQ:CHRS) has announced its financial results for Q3 2020 and nine months ended September 30, 2020, and also provided corporate updates.
Coherus...
Atara Biotherapeutics Inc. (NASDAQ:ATRA) Presents Positive ATA188 Study Data Showing Safety and Sustained Disability...
Atara Biotherapeutics Inc. (NASDAQ:ATRA) has announced the release of efficacy and safety data of its First Phase ATA 188 study in progressive forms of...
Bitcoin Powers Huge Growth Stock Gains (RIOT, AXXA, HVBTF)
The move in Bitcoin to ascend to more than $50K/coin in just a matter of months from under $10K/coin will go down...
Kala Pharmaceuticals Inc. (NASDAQ: KALA) Posts Revenue of $3.1 Million in Q3 2021 and...
Kala Pharmaceuticals Inc. (NASDAQ: KALA) has reported financial results for Q3 2021 ending September 30, 201, and offered a corporate update.
Kala generated revenue of...
MAKE IT MODERN
